Artenimol
|
Artenimol
|
|
| Systematic (IUPAC) name | |
| (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3,-j)-1,2-benzodioxepin-10-ol | |
| Identifiers | |
| CAS number | ? |
| ATC code | P01 |
| PubChem | |
| Chemical data | |
| Formula | C15H24O5 |
| Mol. mass | 284.348 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Artenimol is an antimalarial drug. It is a semi-synthetic derivative of artemisinin.
| Antiprotozoals: Antimalarial drugs (P01B) | |
|---|---|
| Aminoquinolines | Amodiaquine • Chloroquine • Hydroxychloroquine • Pamaquine • Primaquine |
| Biguanides | Proguanil • Cycloguanil embolate |
| Methanolquinolines | Mefloquine • Quinine |
| Diaminopyridines | Pyrimethamine |
| Artemisinin derivatives | Artemisinin • Artemether • Artesunate • Artenimol • Arteether/Artemotil |
| Others | Halofantrine • Lumefantrine |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)


